Literature DB >> 32219696

5-HTTLPR polymorphism and depression risk in Parkinson's disease: an updated meta-analysis.

Pengfei Cheng1, Junxiang Zhang2, Yu Wu3, Wenting Liu2, Jiaying Zhu2, Ze Chen4, Jiarui Zhang4, Songwen Guan4, Yiming Sun4, Jingxia Wang4.   

Abstract

The relationship between the 5-hydroxytryptamine transporter gene-linked polymorphic region (5-HTTLPR) and depression in Parkinson's disease (PD) has remained controversial. Therefore, we conducted this meta-analysis to evaluate the relationship between 5-HTTLPR polymorphisms and depression in PD. Relevant online databases were searched for cross-sectional, case-control or cohort studies examining relations between 5-HTTLPR polymorphisms (S/L) and the risk of developing depression of PD using a meta-analysis. Odd ratios (ORs) of 5-HTTLPR polymorphisms (S/L allele genotype) were calculated between depression in PD and PD for each study. Five observational studies were identified. Overall ORs for 5-HTTLPR S-Allele genotype was 1.98 (95% CI 0.92-4.26) in the dominant model, 1.43 (95% CI 1.08-1.90) in the recessive model, 2.64 (95% CI 1.01-6.88) in the additive model, independently. The overall ORs of S-Allele genotype was 1.51 (95% CI 0.63-3.64) for the Caucasian subgroup, and 1.44 (95% CI 1.05-1.98) for the non-Caucasian subgroup in the recessive model. This meta-analysis indicates that the 5-HTTLPR genotype (S/S-Allele) is correlated with an increased depression risk in PD, and this highlights the needs for these people to take some effective approaches (if any) in prevention of depression of PD before its onset.
© 2020. Belgian Neurological Society.

Entities:  

Keywords:  5-HTTLPR; 5-Hydroxytryptamine transporter; Depression; Gene; Parkinson's disease

Mesh:

Substances:

Year:  2020        PMID: 32219696     DOI: 10.1007/s13760-020-01342-1

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  3 in total

1.  The role of 5-HTTLPR in autism spectrum disorder: New evidence and a meta-analysis of this polymorphism in Latin American population with psychiatric disorders.

Authors:  D L Nuñez-Rios; R Chaskel; A Lopez; L Galeano; M C Lattig
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

2.  Association of DRD4 exon III and 5-HTTLPR VNTR genetic polymorphisms with psychiatric symptoms in hemodialysis patients.

Authors:  Osama Y Alshogran; Laith N Al-Eitan; Shoroq M Altawalbeh; Hatem A Aman
Journal:  PLoS One       Date:  2021-03-30       Impact factor: 3.240

3.  Correlation of common inflammatory cytokines with cognition impairment, anxiety, and depression in acute ischemic stroke patients.

Authors:  Rumei Li; Wenjun Fan; Dongmei Li; Xuesong Liu
Journal:  Braz J Med Biol Res       Date:  2022-02-28       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.